Autoinflammatory bone disorders with special focus on chronic recurrent multifocal osteomyelitis (CRMO)

Pediatric Rheumatology

Volumn 11, Issue 1, 2013, Pages

  Hedrich, Christian M ^a   Hofmann, Sigrun R ^a   Pablik, Jessica ^a   Morbach, Henner ^b   Girschick, Hermann J ^c  

^a UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^b UNIVERSITY OF WÜRZBURG   (Germany)

^c Children's Hospital   (Germany)

Author keywords

Bone; CNO; CRMO; DIRA; IL 10; Inflammation; Majeed; PAPA; TLR4; TNF ; Treatment

Indexed keywords

INTERLEUKIN 1 RECEPTOR BLOCKING AGENT;

ACNE; AUTOINFLAMMATORY DISEASE; BACTERIAL ARTHRITIS; BONE DISEASE; CHRONIC NONBACTERIAL OSTEOMYELITIS; CHRONIC OSTEOMYELITIS; CHRONIC RECURRENT MULTIFOCAL OSTEOMYELITIS; HUMAN; MAJEED SYNDROME; MOLECULAR PATHOLOGY; MONOGENIC DISORDER; OSTEOPATHIC MEDICINE; PRIORITY JOURNAL; PYODERMA GANGRENOSUM; REVIEW;

EID: 84890759943     PISSN: None     EISSN: 15460096     Source Type: Journal    
DOI: 10.1186/1546-0096-11-47     Document Type: Review

References (57)

1. de Almeida J, Goldbach-Mansky R. Monogenic autoinflammatory diseases: concept and clinical manifestations. Clin Immunol 2013, 147:155-174. 10.1016/j.clim.2013.03.016, 23711932.
2. Hofmann SR, Roesen-Wolff A, Hahn G, Hedrich CM. Update: cytokine dysregulation in chronic nonbacterial osteomyelitis (CNO). Int J Rheumatol 2012, 2012:310206. 3364585, 22685464.
3. Morbach H, Hedrich CM, Beer M, Girschick HJ. Autoinflammatory bone disorders. Clin Immunol 2013, 147:185-196. 10.1016/j.clim.2012.12.012, 23369460.
4. Sharma M, Ferguson PJ. Autoinflammatory bone disorders: update on immunologic abnormalities and clues about possible triggers. Curr Opin Rheumatol 2013, 25:658-664. 10.1097/BOR.0b013e328363eb08, 23917160.
5. Ferguson PJ, Sandu M. Current understanding of the pathogenesis and management of chronic recurrent multifocal osteomyelitis. Curr Rheumatol Rep 2012, 14:130-141. 10.1007/s11926-012-0239-5, 3656493, 22359228.
6. Aksentijevich I, Masters SL, Ferguson PJ, Dancey P, Frenkel J, van Royen-Kerkhoff A, et al. An autoinflammatory disease with deficiency of the interleukin-1-receptor antagonist. N Engl J Med 2009, 360:2426-2437. 10.1056/NEJMoa0807865, 2876877, 19494218.
7. Ferguson PJ, Chen S, Tayeh MK, Ochoa L, Leal SM, Pelet A, et al. Homozygous mutations in LPIN2 are responsible for the syndrome of chronic recurrent multifocal osteomyelitis and congenital dyserythropoietic anaemia (Majeed syndrome). J Med Genet 2005, 42:551-557. 10.1136/jmg.2005.030759, 1736104, 15994876.
8. Shoham NG, Centola M, Mansfield E, Hull KM, Wood G, Wise CA, et al. Pyrin binds the PSTPIP1/CD2BP1 protein, defining familial Mediterranean fever and PAPA syndrome as disorders in the same pathway. Proc Natl Acad Sci U S A 2003, 100:13501-13506. 10.1073/pnas.2135380100, 263843, 14595024.
9. Lindor NM, Arsenault TM, Solomon H, Seidman CE, McEvoy MT. A new autosomal dominant disorder of pyogenic sterile arthritis, pyoderma gangrenosum, and acne: PAPA syndrome. Mayo Clin Proc 1997, 72:611-615.
10. Smith EJ, Allantaz F, Bennett L, Zhang D, Gao X, Wood G, et al. Clinical, molecular, and genetic characteristics of PAPA syndrome: a review. Curr Genomics 2010, 11:519-527. 10.2174/138920210793175921, 3048314, 21532836.
11. Waite AL, Schaner P, Richards N, Balci-Peynircioglu B, Masters SL, Brydges SD, et al. Pyrin modulates the intracellular distribution of PSTPIP1. PLoS One 2009, 4:e6147. 10.1371/journal.pone.0006147, 2702820, 19584923.
12. Wise CA, Gillum JD, Seidman CE, Lindor NM, Veile R, Bashiardes S, et al. Mutations in CD2BP1 disrupt binding to PTP PEST and are responsible for PAPA syndrome, an autoinflammatory disorder. Hum Mol Genet 2002, 11:961-969. 10.1093/hmg/11.8.961, 11971877.
13. Moll M, Kuemmerle-Deschner JB. Inflammasome and cytokine blocking strategies in autoinflammatory disorders. Clin Immunol 2013, 147:242-275. 10.1016/j.clim.2013.04.008, 23697917.
14. Stern SM, Ferguson PJ. Autoinflammatory bone diseases. Rheum Dis Clin North Am 2009, 360:735-749.
15. Jesus AA, Osman M, Silva CA, Kim PW, Pham TH, Gadina M, et al. A novel mutation of IL1RN in the deficiency of interleukin-1 receptor antagonist syndrome: description of two unrelated cases from Brazil. Arthritis Rheum 2011, 63:4007-4017. 10.1002/art.30588, 3463867, 22127713.
16. El-Shanti H, Ferguson P. Majeed syndrome. GeneReviews™ [Internet] Seattle (WA): University of Washington, Seattle, Pagon RA, Adam MP, Bird TD, Dolan CR, Fong CT, Stephens K, 1993-2013. 2008.
17. Majeed HA, Kalaawi M, Mohanty D, Teebi AS, Tunjekar MF, al-Gharbawy F, et al. Congenital dyserythropoietic anemia and chronic recurrent multifocal osteomyelitis in three related children and the association with sweet syndrome in two siblings. J Pediatr 1989, 115:730-734. 10.1016/S0022-3476(89)80650-X, 2809904.
18. Ferguson PJ, El-Shanti HI. Autoinflammatory bone disorders. Curr Opin Rheumatol 2007, 19:492-498. 10.1097/BOR.0b013e32825f5492, 17762617.
19. Donkor J, Zhang P, Wong S, O'Loughlin L, Dewald J, Kok BP, et al. A conserved serine residue is required for the phosphatidate phosphatase activity but not the transcriptional coactivator functions of lipin-1 and lipin-2. J Biol Chem 2009, 284:29968-29978. 10.1074/jbc.M109.023663, 2785625, 19717560.
20. Lumeng CN, Saltiel AR. Inflammatory links between obesity and metabolic disease. J Clin Invest 2011, 121:2111-2117. 10.1172/JCI57132, 3104776, 21633179.
21. Valdearcos M, Esquinas E, Meana C, Pena L, Gil-de-Gomez L, Balsinde J, et al. Lipin-2 reduces proinflammatory signaling induced by saturated fatty acids in macrophages. J Biol Chem 2012, 287:10894-10904. 10.1074/jbc.M112.342915, 3322858, 22334674.
22. Herlin T, Fiirgaard B, Bjerre M, Kerndrup G, Hasle H, Bing X, et al. Efficacy of anti-IL-1 treatment in Majeed syndrome. Ann Rheum Dis 2013, 72:410-413. 10.1136/annrheumdis-2012-201818, 23087183.
23. Vittecoq O, Said LA, Michot C, Mejjad O, Thomine JM, Mitrofanoff P, et al. Evolution of chronic recurrent multifocal osteitis toward spondylarthropathy over the long term. Arthritis Rheum 2000, 43:109-119. 10.1002/1529-0131(200001)43:1<109::AID-ANR14>3.0.CO;2-3, 10643706.
24. Hofmann SR, Schwarz T, Moller JC, Morbach H, Schnabel A, Rosen-Wolff A, et al. Chronic non-bacterial osteomyelitis is associated with impaired Sp1 signaling, reduced IL10 promoter phosphorylation, and reduced myeloid IL-10 expression. Clin Immunol 2011, 141:317-327. 10.1016/j.clim.2011.08.012, 21925952.
25. Hofmann SR, Rosen-Wolff A, Tsokos GC, Hedrich CM. Biological properties and regulation of IL-10 related cytokines and their contribution to autoimmune disease and tissue injury. Clin Immunol 2012, 143:116-127. 10.1016/j.clim.2012.02.005, 22459704.
26. Hamel J, Paul D, Gahr M, Hedrich CM. Pilot study: possible association of IL10 promoter polymorphisms with CRMO. Rheumatol Int 2012, 32:555-556. 10.1007/s00296-010-1768-8, 21240493.
27. Hofmann SR, Morbach H, Schwarz T, Rosen-Wolff A, Girschick HJ, Hedrich CM. Attenuated TLR4/MAPK signaling in monocytes from patients with CRMO results in impaired IL-10 expression. Clin Immunol 2012, 145:69-76. 10.1016/j.clim.2012.07.012, 22940633.
28. Lew DP, Waldvogel FA. Osteomyelitis. Lancet 2004, 364:369-379. 10.1016/S0140-6736(04)16727-5, 15276398.
29. Schilling F, Wagner AD. Azithromycin: an anti-inflammatory effect in chronic recurrent multifocal osteomyelitis? A preliminary report. Z Rheumatol 2000, 59:352-353. 10.1007/s003930070059, 11142932.
30. Grange PA, Raingeaud J, Calvez V, Dupin N. Nicotinamide inhibits Propionibacterium acnes-induced IL-8 production in keratinocytes through the NF-kappaB and MAPK pathways. J Dermatol Sci 2009, 56:106-112. 10.1016/j.jdermsci.2009.08.001, 19726162.
31. Jugeau S, Tenaud I, Knol AC, Jarrousse V, Quereux G, Khammari A, et al. Induction of toll-like receptors by Propionibacterium acnes. Br J Dermatol 2005, 153:1105-1113. 10.1111/j.1365-2133.2005.06933.x, 16307644.
32. Cesar-Neto JB, Duarte PM, de Oliveira MC, Tambeli CH, Sallum EA, Nociti FH. Smoking modulates interleukin-6:interleukin-10 and RANKL:osteoprotegerin ratios in the periodontal tissues. J Periodontal Res 2007, 42:184-191. 10.1111/j.1600-0765.2006.00934.x, 17305878.
33. Evans KE, Fox SW. Interleukin-10 inhibits osteoclastogenesis by reducing NFATc1 expression and preventing its translocation to the nucleus. BMC Cell Biol 2007, 8:4. 10.1186/1471-2121-8-4, 1781937, 17239241.
34. Nakashima T, Takayanagi H. Osteoimmunology: crosstalk between the immune and bone systems. J Clin Immunol 2009, 29:555-567. 10.1007/s10875-009-9316-6, 19585227.
35. Nakashima T, Takayanagi H. Osteoclasts and the immune system. J Bone Miner Metab 2009, 27:519-529. 10.1007/s00774-009-0089-z, 19455385.
36. Takayanagi H. Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systems. Nat Rev Immunol 2007, 7:292-304. 10.1038/nri2062, 17380158.
37. Golla A, Jansson A, Ramser J, Hellebrand H, Zahn R, Meitinger T, et al. Chronic recurrent multifocal osteomyelitis (CRMO): evidence for a susceptibility gene located on chromosome 18q21.3-18q22. Eur J Hum Genet 2002, 10:217-221. 10.1038/sj.ejhg.5200789, 11973628.
38. Beck C, Girschick HJ, Morbach H, Schwarz T, Yimam T, Frenkel J, et al. Mutation screening of the IL-1 receptor antagonist gene in chronic non-bacterial osteomyelitis of childhood and adolescence. Clin Exp Rheumatol 2011, 29:1040-1043.
39. Morbach H, Dick A, Beck C, Stenzel M, Muller-Hermelink HK, Raab P, et al. Association of chronic non-bacterial osteomyelitis with Crohn's disease but not with CARD15 gene variants. Rheumatol Int 2010, 30:617-621. 10.1007/s00296-009-1029-x, 19579029.
40. Tam LS, Chan PK, Ho SC, Yu MM, Yim SF, Cheung TH, et al. Natural history of cervical papilloma virus infection in systemic lupus erythematosus - a prospective cohort study. J Rheumatol 2010, 37:330-340. 10.3899/jrheum.090644, 20032093.
41. Khanna G, Sato TS, Ferguson P. Imaging of chronic recurrent multifocal osteomyelitis. Radiographics 2009, 29:1159-1177. 10.1148/rg.294085244, 19605663.
42. Neubauer H, Evangelista L, Morbach H, Girschick H, Prelog M, Kostler H, et al. Diffusion-weighted MRI of bone marrow oedema, soft tissue oedema and synovitis in paediatric patients: feasibility and initial experience. Pediatr Rheumatol Online J 2012, 10:20. 10.1186/1546-0096-10-20, 3508844, 22849717.
43. Girschick HJ, Huppertz HI, Harmsen D, Krauspe R, Muller-Hermelink HK, Papadopoulos T. Chronic recurrent multifocal osteomyelitis in children: diagnostic value of histopathology and microbial testing. Hum Pathol 1999, 30:59-65. 10.1016/S0046-8177(99)90301-5, 9923928.
44. Beck C, Morbach H, Beer M, Stenzel M, Tappe D, Gattenlohner S, et al. Chronic nonbacterial osteomyelitis in childhood: prospective follow-up during the first year of anti-inflammatory treatment. Arthritis Res Ther 2010, 12:R74. 10.1186/ar2992, 2888230, 20433730.
45. Borzutzky A, Stern S, Reiff A, Zurakowski D, Steinberg EA, Dedeoglu F, et al. Pediatric chronic nonbacterial osteomyelitis. Pediatrics 2012, 130:e1190-e1197. 10.1542/peds.2011-3788, 23071213.
46. Twilt M, Laxer RM. Clinical care of children with sterile bone inflammation. Curr Opin Rheumatol 2011, 23:424-431. 10.1097/BOR.0b013e328349c363, 21788901.
47. Hedrich CM, Hahn G, Girschick HJ, Morbach H. A clinical and pathomechanistic profile of chronic nonbacterial osteomyelitis/chronic recurrent multifocal osteomyelitis and challenges facing the field. Expert Rev Clin Immunol 2013, 9:845-854. 10.1586/1744666X.2013.824670, 24070048.
48. Girschick HJ, Zimmer C, Klaus G, Darge K, Dick A, Morbach H. Chronic recurrent multifocal osteomyelitis: what is it and how should it be treated?. Nat Clin Pract Rheumatol 2007, 3:733-738. 10.1038/ncprheum0653, 18037933.
49. Jansson A, Renner ED, Ramser J, Mayer A, Haban M, Meindl A, et al. Classification of non-bacterial osteitis: retrospective study of clinical, immunological and genetic aspects in 89 patients. Rheumatology (Oxford) 2007, 46:154-160. 10.1093/rheumatology/kel190, 16782988.
50. Hospach T, Langendoerfer M, von Kalle T, Maier J, Dannecker GE. Spinal involvement in chronic recurrent multifocal osteomyelitis (CRMO) in childhood and effect of pamidronate. Eur J Pediatr 2010, 169:1105-1111. 10.1007/s00431-010-1188-5, 20339868.
51. Miettunen PM, Wei X, Kaura D, Reslan WA, Aguirre AN, Kellner JD. Dramatic pain relief and resolution of bone inflammation following pamidronate in 9 pediatric patients with persistent chronic recurrent multifocal osteomyelitis (CRMO). Pediatr Rheumatol Online J 2009, 7:2. 10.1186/1546-0096-7-2, 2631594, 19138427.
52. Morbach H, Stenzel M, Girschick HJ. Bisphosphonate treatment for patients with chronic nonbacterial osteomyelitis. Nat Clin Pract Rheumatol 2008, 4:570-571. 10.1038/ncprheum0908, 18797428.
53. Simm PJ, Allen RC, Zacharin MR. Bisphosphonate treatment in chronic recurrent multifocal osteomyelitis. J Pediatr 2008, 152:571-575. 10.1016/j.jpeds.2007.08.047, 18346517.
54. Chitu V, Nacu V, Charles JF, Henne WM, McMahon HT, Nandi S, et al. PSTPIP2 deficiency in mice causes osteopenia and increased differentiation of multipotent myeloid precursors into osteoclasts. Blood 2012, 120:3126-3135. 10.1182/blood-2012-04-425595, 3471520, 22923495.
55. Grosse J, Chitu V, Marquardt A, Hanke P, Schmittwolf C, Zeitlmann L, et al. Mutation of mouse Mayp/Pstpip2 causes a macrophage autoinflammatory disease. Blood 2006, 107:3350-3358. 10.1182/blood-2005-09-3556, 1895761, 16397132.
56. Safra N, Johnson EG, Lit L, Foreman O, Wolf ZT, Aguilar M, et al. Clinical manifestations, response to treatment, and clinical outcome for Weimaraners with hypertrophic osteodystrophy: 53 cases (2009-2011). J Am Vet Med Assoc 2013, 242:1260-1266. 10.2460/javma.242.9.1260, 23600784.
57. Woodard JC. Canine hypertrophic osteodystrophy, a study of the spontaneous disease in littermates. Vet Pathol 1982, 19:337-354. 10.1177/030098588201900401, 6806967.